Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests
January 18, 2018 from 1:00 – 2:00 PM ET
PowerPoint Presentation (PDF, 442 KB)
FAQs (PDF, 134 KB)
Erica S. Breslau, Ph.D., M.P.H.
Health Systems and Interventions Research Branch
Healthcare Delivery Research Program
Division of Cancer Control and Population Sciences
This webinar provides an overview of the Funding Opportunity Announcement (FOA), Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) [PA-17-495]. This FOA encourages applications that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, cervical, colorectal, or lung cancers. Applications should propose to intervene at two or more levels—including patient, provider, clinical team, clinic, healthcare institution, and/or community setting—and measure outcomes at three or more levels, while accounting for interactions that occur between and across levels.
Last Updated: 14 Sep 2018